| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |